Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum. Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations. Diabetes Care 2015;38:2033-2041.
Beltrand J, Elie C, Busiah K, Fournier E, Boddaert N, Bahi-Buisson N, Vera M, Bui-Quoc E, Ingster-Moati I, Berdugo M, Simon A, Gozalo C, Djerada Z, Flechtner I, Treluyer JM, Scharfmann R, Cavé H, Vaivre-Douret L, Polak M; GlidKir Study Group. Beltrand J, et al. Among authors: gozalo c. Diabetes Care. 2016 Jan;39(1):175. doi: 10.2337/dc16-er01. Diabetes Care. 2016. PMID: 26696658 No abstract available.
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Beltrand J, Elie C, Busiah K, Fournier E, Boddaert N, Bahi-Buisson N, Vera M, Bui-Quoc E, Ingster-Moati I, Berdugo M, Simon A, Gozalo C, Djerada Z, Flechtner I, Treluyer JM, Scharfmann R, Cavé H, Vaivre-Douret L, Polak M; GlidKir Study Group. Beltrand J, et al. Among authors: gozalo c. Diabetes Care. 2015 Nov;38(11):2033-41. doi: 10.2337/dc15-0837. Epub 2015 Oct 5. Diabetes Care. 2015. PMID: 26438614 Clinical Trial.
Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.
Beltrand J, Baptiste A, Busiah K, Bouazza N, Godot C, Boucheron A, Djerada Z, Gozalo C, Berdugo M, Tréluyer JM, Elie C, Polak M; GLID-KIR study group. Beltrand J, et al. Among authors: gozalo c. Pediatr Diabetes. 2019 May;20(3):246-254. doi: 10.1111/pedi.12823. Epub 2019 Feb 21. Pediatr Diabetes. 2019. PMID: 30684309 Clinical Trial.
A Slight Smell of Lemon.
Feliu C, Cazaubon Y, Fouley A, Guillemin H, Gozalo C, Djerada Z. Feliu C, et al. Among authors: gozalo c. Ther Drug Monit. 2017 Jun;39(3):205-207. doi: 10.1097/FTD.0000000000000397. Ther Drug Monit. 2017. PMID: 28338527
The antidiabetic drug glibenclamide exerts direct retinal neuroprotection.
Berdugo M, Delaunay K, Naud MC, Guegan J, Moulin A, Savoldelli M, Picard E, Radet L, Jonet L, Djerada Z, Gozalo C, Daruich A, Beltrand J, Jeanny JC, Kermorvant-Duchemin E, Crisanti P, Polak M, Behar-Cohen F. Berdugo M, et al. Among authors: gozalo c. Transl Res. 2021 Mar;229:83-99. doi: 10.1016/j.trsl.2020.10.003. Epub 2020 Oct 17. Transl Res. 2021. PMID: 33080394 Free article.
35 results